Đại học Phan Châu Trinh
Đại học Phan Châu Trinh
Tuyển Sinh Đại Học
Tuyển sinh Đại học 2024
Kết nối với chúng tôi qua Zalo:

Liên hệ tuyển sinh

Gửi email cho chúng tôi:
Gọi hoặc Zalo cho chúng tôi:
Gửi hồ sơ về:
09 Nguyễn Gia Thiều, P. Điện Ngọc, TX. Điện Bàn, Quảng Nam
Theo dõi chúng tôi trên mạng xã hội
Theo dõi chúng tôi trên phương tiện truyền thông xã hội để không bỏ lỡ thông tin quan trọng về đăng ký, học bổng, cơ hội nghề nghiệp hấp dẫn và trải nghiệm đa dạng trong các hoạt động của chúng tôi.

New Issue: Scopolamine Butylbromide for End-of-Life Death Rattle, Pulmonary Embolism Workups in COPD Exacerbation, Eosinophilic Esophagitis Review, and more

Trouble viewing this email? Read it Online

JAMA Table of Contents: Read the latest issue of JAMA, the Journal of the American Medical Association, a publication of the JAMA Network, online Advertisement

 

 

 

 

 

JAMA masthead

New Issue

OCTOBER 5, 2021; VOLUME 326, NUMBER 13,
facebook icon twitter icon linked in icon pinterest icon youtube icon instagram icon

IN THIS ISSUE OF JAMA

Audio Highlights

Audio Editors' Summary: Scopolamine Butylbromide for End-of-Life Death Rattle, Pulmonary Embolism Workups in COPD Exacerbation, Eosinophilic Esophagitis review, and more

ORIGINAL INVESTIGATION

Caring for the Critically Ill Patient

Effect of Prophylactic Subcutaneous Scopolamine Butylbromide on Death Rattle in Patients at the End of Life: The SILENCE Randomized Clinical Trial

Harriëtte J. van Esch, MD; Lia van Zuylen, MD, PhD; Eric C. T. Geijteman, MD, PhD; et al.

Audio Author Interview: Scopolamine Butylbromide for Preventing End-of-Life Death Rattle

Editorial: Preventing Death Rattle With Prophylactic Subcutaneous Scopolamine Butylbromide; Jared R. Lowe, MD; Laura C. Hanson, MD, MPH

Effect of a Pulmonary Embolism Diagnostic Strategy on Clinical Outcomes in Patients Hospitalized for COPD Exacerbation: A Randomized Clinical Trial

David Jiménez, MD, PhD; Alvar Agustí, MD, PhD; Eva Tabernero, MD; et al.

Earn CME credit

Trends in Cardiovascular Risk Factors in US Adults by Race and Ethnicity and Socioeconomic Status, 1999-2018

Jiang He, MD, PhD; Zhengbao Zhu, MD, PhD; Joshua D. Bundy, PhD, MPH; et al.

US Emergency Department Visits Attributed to Medication Harms, 2017-2019

Daniel S. Budnitz, MD, MPH; Nadine Shehab, PharmD, MPH; Maribeth C. Lovegrove, MPH; et al.

RESEARCH LETTER

Mask-Wearing Behavior at the 2021 NCAA Men’s Basketball Tournament

Joshua R. Vest, PhD, MPH; Justin Blackburn, PhD; Shama Cash-Goldwasser, MD, MPH; et al.

Earn CME credit

Physician Practice Interruptions in the Treatment of Medicare Patients During the COVID-19 Pandemic

Hannah T. Neprash, PhD; Michael E. Chernew, PhD

VIEWPOINT

Strengthening Global Health Security and Reforming the International Health Regulations: Making the World Safer From Future Pandemics

Antony J. Blinken, JD; Xavier Becerra, JD

An International Agreement on Pandemic Prevention and Preparedness

Lawrence O. Gostin, JD; Sam F. Halabi, JD, MPhil; Kevin A. Klock, JD

Holding Hope for Patients With Serious Illness

Abby Rosenberg, MD, MS, MA; Robert M Arnold, MD; Yael Schenker, MD, MAS

A PIECE OF MY MIND

Good Enough for Whom?

Sharon Reece, MD

EDITORIAL

Preventing Death Rattle With Prophylactic Subcutaneous Scopolamine Butylbromide

Jared R. Lowe, MD; Laura C. Hanson, MD, MPH

Audio Author Interview: Scopolamine Butylbromide for Preventing End-of-Life Death Rattle

Ninth International Congress on Peer Review and Scientific Publication: Call for Abstracts

John P. A. Ioannidis, MD, DSc; Michael Berkwits, MD, MSCE; Annette Flanagin, RN, MA; et al.

REVIEW

Eosinophilic Esophagitis: A Review

Amanda Muir, MD, MSTR; Gary W. Falk, MD, MS

Earn CME credit

JAMA INSIGHTS

Infectious Keratitis in 2021

Marlene L. Durand, MD; Miriam Baron Barshak, MD; James Chodosh, MD, MPH

JAMA CLINICAL GUIDELINES SYNOPSIS

Inferior Vena Cava Filters for the Treatment of Patients With Venous Thromboembolic Disease

Osman Ahmed, MD; Adam S. Cifu, MD; Jonathan Paul, MD

MEDICAL NEWS & PERSPECTIVES

How COVID-19 Made It Even Tougher to Know ICU Patients as Individuals

Rita Rubin, MA

JAMA Medical News Audio: Rebounding From COVID-19’s Reversal of Recent Progress in the ICU

Quick Uptakes

Choose ARBs Over ACE Inhibitors for First-line Hypertension Treatment, Large New Analysis Suggests

Jennifer Abbasi

NEWS FROM THE JAMA NETWORK

Pediatric Depression and Anxiety Doubled During the Pandemic

Anita Slomski

Cycling May Lower Mortality Risk in People Who Have Diabetes

Anita Slomski

Oral Upadacitinib Beats Subcutaneous Dupilumab for Atopic Dermatitis

Anita Slomski

Study Projects Lifetime Benefits of Dapagliflozin in HFrEF

Anita Slomski

NEWS FROM THE FOOD AND DRUG ADMINISTRATION

Mandated Education for Opioid Prescribers Is Up for Discussion

Rebecca Voelker, MSJ

A First in Stroke Rehabilitation

Rebecca Voelker, MS

FDA Reaches a Milestone in Generic Drug Approvals

Rebecca Voelker, MSJ

THE ARTS AND MEDICINE

Japanese Medical Mnemonics—Language, Reflection, and Art

Nick Love, MD, PhD; Yuichi J. Shimada, MD, MPH

POETRY AND MEDICINE

Every Time

Alex Ruuska, BA, BS

JAMA REVISITED

Modern Problems in Two Medical Specialties

JAMA PATIENT PAGE

Intermittent Fasting

Zhaoping Li, MD, PhD; David Heber, MD, PhD

AUDIO

Audio Editors' Summary

Scopolamine Butylbromide for End-of-Life Death Rattle, Pulmonary Embolism Workups in COPD Exacerbation, Eosinophilic Esophagitis review, and more

Audio Author Interview

Scopolamine Butylbromide for Preventing End-of-Life Death Rattle

JAMA Medical News Audio

Rebounding From COVID-19’s Reversal of Recent Progress in the ICU

COMMENT & RESPONSE

US Preventive Services Task Force Recommendation Statement on Screening for Colorectal Cancer

Shida Haghighat, MD, MPH; Daniel A. Sussman, MD, MSPH; Amar Deshpande, MD

Audio Clinical Review: USPSTF Recommendation: Screening for Colorectal Cancer

US Preventive Services Task Force Recommendation Statement on Screening for Colorectal Cancer—Reply

Michael J. Barry, MD; Karina Davidson, PhD, MASc; Carol M. Mangione, MD, MSPH

Continuous Glucose Monitoring and Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin

Kevin Cowart, PharmD, MPH; Nicholas W. Carris, PharmD

Continuous Glucose Monitoring and Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin

Wellbert Hernández-Núñez, MD; Jesús Zacarías Villareal-Pérez, MD; René Rodríguez-Gutiérrez, MD, MSc, PhD

Continuous Glucose Monitoring and Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin—Reply

Thomas W. Martens, MD; Roy W. Beck, MD, PhD; Richard M. Bergenstal, MD

CORRECTION

Incorrect Value in Table

Error in Figure

Transposed Column Heads in Table

JAMA MASTHEAD

JAMA

Be part of the story. Follow JAMA Network on Instagram.

JAMA Network signature

Thank you for subscribing to JAMA Network email alerts. This message was sent to buiduytam1@gmail.com by updates@jamanetwork.org.

To update your contact information, change your email preferences, or unsubscribe, click here.

To ensure you always receive JAMA Network emails, add the email address updates@jamanetwork.org to your address book.

To unsubscribe by mail, contact:

JAMA Network
AMA Plaza
330 N Wabash Ave
Chicago, IL 60611
Or call (800) 621-8335.

facebook icon twitter icon linked in icon pinterest icon youtube icon instagram icon

©2021 American Medical Association. All rights reserved.
 

JAMA Network
PCTU pctu Hội nghị khoa học